Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  aminolevulinic acid hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-23 of 23 for your search:
Start Over
Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: PDT for Lip, NCT00868088
Treating Actinic Keratoses With Natural Daylight PDT: Comparing Two Light Sensitizers (ALA and MAL)
Phase: Phase IV
Type: Health services research, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: R13073 / Q257, 2013-002108-15, NCT01893203
Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas
Phase: Phase III
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: NPC-07-1, NCT01167322
Combination Therapy With 5-FU and PDT for the Treatment of Post-transplant Premalignant Skin Disease
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-1050, 1R21CA156227-01A1, NCT01525329
Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis With Photodynamic Therapy
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALA-AK-CT007, 2013-002510-12, NCT01966120
Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 14-374, NCT02124733
Treatment of Oral Premalignant Lesions With 5-ALA PDT
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 51439, NCT00571974
Photodynamic Therapy in Treating Patients With Skin Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: DS 92-42, RPCI-DS-92-42, NCI-V97-1191, NCT00002963
Photodynamic Therapy in Treating Patients With Skin Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000065494, RPCI-DS-96-55, NCI-G97-1224, NCT00002975
Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: DS 97-32, RPCI-DS-9732, NCT00054171
Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000696316, CRUK-UCL-09-0398, 2010-022496-66, 09/0398, 10/H0304/100, UCL/09/0398 v2.0, GALA-5, EUDRACT-2010-022496-66, NCT01310868
A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 5-ALA-01, NCT01403311
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP0106, NCT01458587
Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP0105, NCT01475955
Trial Comparing the Effects of Intermittent Vismodegib Versus Photodynamic Therapy in Patients With Multiple Basal Cell Carcinomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2011-077, ML28244, NCT01556009
Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Phase: Phase I
Type: Diagnostic, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: 4079, NCT00671710
Fluorescence Guided Resection of Brain Tumors
Phase: Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: DMS 0711, R01 NS052274-01A2, NCT00870779
Photodynamic Therapy for Early Head and Neck Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 18308, NCT01019954
Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE-9Z07-CC417, P30CA043703, P01CA084203, NCT00663910
Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses
Phase: No phase specified
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: INV-0901, NCT01053000
Photodynamic Therapy of Actinic Keratoses With Alacare®
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NIS 01, NCT01571336
The Use of Microneedles in Photodynamic Therapy
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 282150, NCT01812837
Start Over